Biodexa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Biodexa Pharmaceuticals has a total shareholder equity of £4.7M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £10.5M and £5.9M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£5.97m |
Equity | UK£4.68m |
Total liabilities | UK£5.86m |
Total assets | UK£10.54m |
Financial Position Analysis
Short Term Liabilities: BDRX's short term assets (£7.0M) exceed its short term liabilities (£5.6M).
Long Term Liabilities: BDRX's short term assets (£7.0M) exceed its long term liabilities (£295.0K).
Debt to Equity History and Analysis
Debt Level: BDRX is debt free.
Reducing Debt: BDRX has no debt compared to 5 years ago when its debt to equity ratio was 5.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BDRX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BDRX has less than a year of cash runway if free cash flow continues to grow at historical rates of 13.2% each year.